About Enancio
Enancio is a company based in Cesson-sevigne (France) founded in 2015 by Guillaume Rizk and Yvan Le Bras was acquired by Illumina in July 2020. Enancio operates in a competitive market with competitors including DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others.
- Headquarter Cesson-sevigne, France
- Founders Guillaume Rizk, Yvan Le Bras
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Enancio
Detailed funding history for Enancio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Enancio
Enancio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Illumina.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of technologies for analysis of genetic variation and function
|
Locked | Locked | Locked |
Investor details for Enancio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Enancio
Investment portfolio details for Enancio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Enancio
Detailed financials for Enancio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Enancio Comparisons
Peer comparison for Enancio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Enancio
Enancio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
Platforms for genomic data analysis and management are provided.
|
Detailed competitors of Enancio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Enancio
Complete news archive for Enancio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enancio
Enancio was founded in 2015.
Enancio is headquartered in Cesson-sevigne, France. It is registered at Cesson-sevigne, Ille-et-vilaine, France.
Jennifer Del Giudice is the current CEO of Enancio.
Enancio was founded in 2015 and is based in Cesson Sevigne, France. Operations focus on the biotechnology sector, where next-generation sequencing analysis is delivered through proprietary software called Lena. This software handles biological data, with specialization in the compression of fastq files and genomic datasets. Services support research and analysis needs in genomics.
Enancio's top competitors include DNAnexus, Depixus and Ingenuity Systems.
Enancio has 1 investor. Key investors include Illumina.